1. Home
  2. STKL vs EYPT Comparison

STKL vs EYPT Comparison

Compare STKL & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKL
  • EYPT
  • Stock Information
  • Founded
  • STKL 1973
  • EYPT 1987
  • Country
  • STKL United States
  • EYPT United States
  • Employees
  • STKL N/A
  • EYPT N/A
  • Industry
  • STKL Precious Metals
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • STKL Basic Materials
  • EYPT Industrials
  • Exchange
  • STKL Nasdaq
  • EYPT Nasdaq
  • Market Cap
  • STKL 644.1M
  • EYPT 741.0M
  • IPO Year
  • STKL N/A
  • EYPT 2005
  • Fundamental
  • Price
  • STKL $6.13
  • EYPT $11.09
  • Analyst Decision
  • STKL Strong Buy
  • EYPT Strong Buy
  • Analyst Count
  • STKL 2
  • EYPT 7
  • Target Price
  • STKL $9.50
  • EYPT $24.29
  • AVG Volume (30 Days)
  • STKL 1.0M
  • EYPT 643.4K
  • Earning Date
  • STKL 08-06-2025
  • EYPT 08-06-2025
  • Dividend Yield
  • STKL N/A
  • EYPT N/A
  • EPS Growth
  • STKL N/A
  • EYPT N/A
  • EPS
  • STKL N/A
  • EYPT N/A
  • Revenue
  • STKL $762,882,000.00
  • EYPT $51,898,000.00
  • Revenue This Year
  • STKL $10.94
  • EYPT N/A
  • Revenue Next Year
  • STKL $8.49
  • EYPT N/A
  • P/E Ratio
  • STKL N/A
  • EYPT N/A
  • Revenue Growth
  • STKL 11.44
  • EYPT 2.99
  • 52 Week Low
  • STKL $3.65
  • EYPT $3.91
  • 52 Week High
  • STKL $8.11
  • EYPT $13.99
  • Technical
  • Relative Strength Index (RSI)
  • STKL 51.00
  • EYPT 61.85
  • Support Level
  • STKL $5.15
  • EYPT $10.22
  • Resistance Level
  • STKL $6.54
  • EYPT $11.28
  • Average True Range (ATR)
  • STKL 0.30
  • EYPT 0.71
  • MACD
  • STKL 0.03
  • EYPT 0.04
  • Stochastic Oscillator
  • STKL 70.50
  • EYPT 89.89

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: